Literature DB >> 12622659

A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.

Lewis L Judd1, Hagop S Akiskal, Pamela J Schettler, William Coryell, Jean Endicott, Jack D Maser, David A Solomon, Andrew C Leon, Martin B Keller.   

Abstract

BACKGROUND: This is the first prospective longitudinal study, to our knowledge, of the natural history of the weekly symptomatic status of bipolar II disorder (BP-II).
METHODS: Weekly affective symptom status ratings for 86 patients with BP-II were based on interviews conducted at 6- or 12-month intervals during a mean of 13.4 years of prospective follow-up. Percentage of weeks at each symptom severity level and the number of shifts in symptom status and polarity were examined. Predictors of chronicity for BP-II were evaluated using new chronicity measures. Chronicity was also analyzed in relation to the percentage of follow-up weeks with different types of somatic treatment.
RESULTS: Patients with BP-II were symptomatic 53.9% of all follow-up weeks: depressive symptoms (50.3% of weeks) dominated the course over hypomanic (1.3% of weeks) and cycling/mixed (2.3% of weeks) symptoms. Subsyndromal, minor depressive, and hypomanic symptoms combined were 3 times more common than major depressive symptoms. Longer intake episodes, a family history of affective disorders, and poor previous social functioning predicted greater chronicity. Prescribed somatic treatment did not correlate significantly with symptom chronicity. Patients with BP-II of brief (2-6 days) vs longer (> or =7 days) hypomanias were not significantly different on any measure.
CONCLUSIONS: The longitudinal symptomatic course of BP-II is chronic and is dominated by depressive rather than hypomanic or cycling/mixed symptoms. Symptom severity fluctuates frequently within the same patient over time, involving primarily symptoms of minor and subsyndromal severity. Longitudinally, BP-II is expressed as a dimensional illness involving the full severity range of depressive and hypomanic symptoms. Hypomania of long or short duration in BP-II seems to be part of the same disease process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12622659     DOI: 10.1001/archpsyc.60.3.261

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  235 in total

1.  Rechallenge with lamotrigine after a rash: a prospective case series and review of the literature.

Authors:  Chris B Aiken; Carolyn Orr
Journal:  Psychiatry (Edgmont)       Date:  2010-05

2.  Depressive episodes and symptoms dominate the longitudinal course of bipolar disorder.

Authors:  Lewis L Judd; Hagop S Akiskal
Journal:  Curr Psychiatry Rep       Date:  2003-12       Impact factor: 5.285

3.  Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes.

Authors:  Lewis L Judd; Pamela J Schettler; Hagop Akiskal; William Coryell; Jan Fawcett; Jess G Fiedorowicz; David A Solomon; Martin B Keller
Journal:  J Affect Disord       Date:  2012-02-06       Impact factor: 4.839

4.  Bipolar spectrum disorders in primary care: optimising diagnosis and treatment.

Authors:  Daniel J Smith; Ajay Thapar; Sharon Simpson
Journal:  Br J Gen Pract       Date:  2010-05       Impact factor: 5.386

5.  Regional fMRI hypoactivation and altered functional connectivity during emotion processing in nonmedicated depressed patients with bipolar II disorder.

Authors:  Nathalie Vizueta; Jeffrey D Rudie; Jennifer D Townsend; Salvatore Torrisi; Teena D Moody; Susan Y Bookheimer; Lori L Altshuler
Journal:  Am J Psychiatry       Date:  2012-08       Impact factor: 18.112

6.  The association between insomnia-related sleep disruptions and cognitive dysfunction during the inter-episode phase of bipolar disorder.

Authors:  Jennifer C Kanady; Adriane M Soehner; Alexandra B Klein; Allison G Harvey
Journal:  J Psychiatr Res       Date:  2017-01-05       Impact factor: 4.791

7.  An Integrated Risk Reduction Intervention can reduce body mass index in individuals being treated for bipolar I disorder: results from a randomized trial.

Authors:  Ellen Frank; Meredith L Wallace; Martica Hall; Brant Hasler; Jessica C Levenson; Carol A Janney; Isabella Soreca; Matthew C Fleming; Joan Buttenfield; Fiona C Ritchey; David J Kupfer
Journal:  Bipolar Disord       Date:  2014-12-12       Impact factor: 6.744

8.  Positive Affect Enhances the Association of Hypomanic Personality and Cognitive Flexibility.

Authors:  Daniel Fulford; Greg Feldman; Benjamin A Tabak; Morgan McGillicuddy; Sheri L Johnson
Journal:  Int J Cogn Ther       Date:  2013-03-01

9.  Are adults with bipolar disorder active? Objectively measured physical activity and sedentary behavior using accelerometry.

Authors:  Carol A Janney; Andrea Fagiolini; Holly A Swartz; John M Jakicic; Robert G Holleman; Caroline R Richardson
Journal:  J Affect Disord       Date:  2013-09-18       Impact factor: 4.839

10.  Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD Study.

Authors:  Rodrigo Machado-Vieira; David A Luckenbaugh; Elizabeth D Ballard; Ioline D Henter; Mauricio Tohen; Trisha Suppes; Carlos A Zarate
Journal:  Am J Psychiatry       Date:  2016-08-13       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.